Glucose Metabolism and Stress Hyperglycemia in Critically Ill Children.
Vijay SrinivasanPublished in: Indian journal of pediatrics (2023)
Abnormalities in glucose metabolism and stress hyperglycemia (SH) are commonly seen in critically ill children. While SH may represent an adaptive stress response as a source of fuel for the body during the "fight or flight response" of critical illness, several studies have observed the association of SH with worse outcomes in different disease states. In addition to alterations in glucose metabolism and acquired insulin resistance from inflammation and organ dysfunction, specific intensive care unit (ICU) interventions can also affect glucose homeostasis and SH during critical illness. Common ICU interventions can mediate the development of SH in critical illness. The strategy of tight glucose control combined with intensive insulin therapy (TGC-IIT) has been well studied to improve outcomes in both adult and pediatric critical illness. Though early single-center studies of TGC-IIT observed benefits with better outcomes albeit with greater incidence of hypoglycemia, subsequent larger multicenter studies in both children and adults have not conclusively demonstrated benefits and have even observed harm. Several possible reasons for these contrasting results include differences in patient populations, glycemic control targets, and glucose control protocols including nutrition support, and variability in achieving these targets, measurement methods, and expertise in protocol implementation. Future studies may need to individualize management of SH in critically ill children with improved monitoring of indices of glycemia utilizing continuous sensors and closed-loop insulin administration.
Keyphrases
- glycemic control
- type diabetes
- intensive care unit
- blood glucose
- young adults
- insulin resistance
- physical activity
- oxidative stress
- case control
- mechanical ventilation
- randomized controlled trial
- healthcare
- stem cells
- adipose tissue
- risk factors
- primary care
- case report
- clinical trial
- metabolic syndrome
- blood brain barrier
- cross sectional
- stress induced
- current status
- replacement therapy
- cell therapy